Ursodeoxycholic acid for managing drug-induced liver injury: Role of hepatoprotective and anti-cholestatic mechanisms Dr. Kamal Kant Kohli27 March 2025 9:00 PM ISTDrug-induced liver injury (DILI) is a significant concern in clinical practice, arising from medications, herbs, and dietary supplements. It can...
Gilead Seladelpar gets Conditional European Marketing Authorization for Primary Biliary Cholangitis Ruchika Sharma23 Feb 2025 11:30 AM ISTFoster City: Gilead Sciences, Inc. has received conditional marketing authorization from the European Commission (EC) for Seladelpar for the treatment...
Ursodeoxycholic acid may Reduce need of Cholecystectomy for gallstones after laparoscopic sleeve gastrectomy: Study Dr. Shravani Dali14 Feb 2025 9:15 PM ISTUrsodeoxycholic acid may Reduce the need for Cholecystectomy for gallstones after laparoscopic sleeve gastrectomy suggests a study published in the...
Abbott India Gets CDSCO Panel Nod To Conduct Phase III CT of Ursodeoxycholic Acid tablet Dr. Divya Colin6 Jan 2025 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to the drug...
Gilead Sciences Seladelpar gets positive CHMP opinion for Primary Biliary Cholangitis Ruchika Sharma15 Dec 2024 12:00 PM ISTFoster City: Gilead Sciences, Inc. has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...
Abbott Healthcare Gets CDSCO Panel Nod To Manufacture Market Ursodeoxycholic acid for Obstetric Cholestasis Dr. Divya Colin1 Dec 2024 5:15 PM ISTNew Delhi: Abbott Healthcare has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Shilpa Pharma Lifesciences receives certificate of suitability from EDQM for Ursodeoxycholic Acid Ruchika Sharma1 Aug 2024 2:26 PM ISTKarnataka: Shilpa Medicare Limited's 100 percent subsidiary, Shilpa Pharma Lifesciences Limited has received certificate of suitability (CEP)...
Conduct Phase III CT of Ursodeoxycholic acid for Non-alcoholic fatty liver disease: CDSCO Panael Tell Abbott Dr. Divya Colin10 March 2024 6:00 PM ISTNew Delhi: In response to the proposal presented by the drug major Abbott for the additional indication for the already marketed formulation...
CDSCO Panel Grants Abbott's Protocol Amendment Proposal For Ursodeoxycholic Acid Dr. Divya Colin15 April 2023 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has accepted Abbott's phase III...
Liver drug may prevent and lower severity of COVID 19 infection Dr. Kamal Kant Kohli7 April 2023 9:30 AM ISTResearchers have found in a new study that Liver drug ursodeoxycholic acid (UDCA) may prevent and lower severity of COVID 19 infection.Ursodeoxycholic...
Ursodeoxycholic acid helps prevent gallstones formation after Bariatric surgery, Study finds Medical Dialogues Editorial Team10 May 2022 7:00 PM ISTIn a new study published in Obesity it was shown that Ursodeoxycholic acid (UDCA) can successfully prevent gallstone development after bariatric...
Ursodeoxycholic acid fails to prevent gallstones after bariatric surgery: Lancet MD Editorial Team26 Nov 2021 9:00 AM ISTNetherlands: A multicenter study by Sylke Haal, MD, and team revealed that the occurrence of symptomatic gallstone disease was not significantly...
